SEREVENTDISKUS (Dispensing Solutions, Inc.)


Welcome to the PulseAid listing for the SEREVENT drug offered from Dispensing Solutions, Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Dispensing Solutions, Inc.
NON-PROPRIETARY NAME: salmeterol xinafoate
SUBSTANCE NAME: SALMETEROL XINAFOATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: ORAL; RESPIRATORY (INHALATION)
DOSAGE FORM: POWDER, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-11-25
END MARKETING DATE: 0000-00-00


SEREVENT DISKUS HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSEREVENT DISKUS from Dispensing Solutions, Inc.
LABELER NAME: Dispensing Solutions, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/1)
START MARKETING DATE: 1997-11-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 68258-8961_198f20a2-218e-4a0f-a4c1-ae7c3b62e1c6
PRODUCT NDC: 68258-8961
APPLICATION NUMBER: NDA020692

Other SALMETEROL XINAFOATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.SEREVENT
GlaxoSmithKline LLCSEREVENT